Get started
CARDLYTICS INCCARDLYTICS INCCARDLYTICS INC

CARDLYTICS INC

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

CYX chart

Upcoming earnings

Next report date
Report period
Q1 2024
EPS estimate
−0.40EUR
Revenue estimate
‪66.44 M‬EUR

Key stats

Market capitalization
‪506.18 M‬EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3.13EUR
Net income (FY)
‪−122.04 M‬EUR
Revenue (FY)
‪280.14 M‬EUR
Shares float
‪41.10 M‬
Beta (1Y)
2.80

About Cardlytics, Inc. Common Stock

Sector
Technology Services
Industry
Internet Software/Services
CEO
Karim Temsamani
Website
cardlytics.com
Headquarters
Atlanta
Employees (FY)
434
Founded
2008
Cardlytics, Inc. engages in the business of operating an advertising platform which includes online, mobile applications, email, and various real-time notifications. It operates under the Cardlytics and Bridg Platforms. The Cardlytics Platform segment focuses on the United States and the United Kingdom, which represents proprietary advertising channels. The Bridg Platform segment is involved in utilizing POS data from merchant data partners, including product-level purchase data to enable marketers to perform analytics and targeted loyalty marketing in a privacy protected manner. The company was founded by Scott David Grimes, Lynne Marie Laube, and Hans Theisen on June 26, 2008 and is headquartered in Atlanta, GA.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CYX is 11.31 EUR — it has increased by 4.00% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange CARDLYTICS INC stocks are traded under the ticker CYX.
CARDLYTICS INC is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
CYX stock is 6.05% volatile and has beta coefficient of 2.80. Check out the list of the most volatile stocks — is CARDLYTICS INC there?
CYX earnings for the last quarter are −0.60 EUR per share, whereas the estimation was −0.61 EUR resulting in a 3.08% surprise. The estimated earnings for the next quarter are −0.21 EUR per share. See more details about CARDLYTICS INC earnings.
CARDLYTICS INC revenue for the last quarter amounts to ‪74.74 M‬ EUR despite the estimated figure of ‪75.73 M‬ EUR. In the next quarter revenue is expected to reach ‪81.13 M‬ EUR.
Yes, you can track CARDLYTICS INC financials in yearly and quarterly reports right on TradingView.
CYX stock has risen by 1.03% compared to the previous week, the month change is a 8.79% fall, over the last year CARDLYTICS INC has showed a 105.64% increase.
CYX net income for the last quarter is ‪−91.36 M‬ EUR, while the quarter before that showed ‪−22.67 M‬ EUR of net income which accounts for −302.97% change. Track more CARDLYTICS INC financial stats to get the full picture.
Today CARDLYTICS INC has the market capitalization of ‪506.18 M‬, it has increased by 1.06% over the last week.
No, CYX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CYX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CARDLYTICS INC stock right from TradingView charts — choose your broker and connect to your account.
CYX reached its all-time high on Feb 16, 2021 with the price of 131.00 EUR, and its all-time low was 2.40 EUR and was reached on Mar 28, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 27, 2024, the company has 434.00 employees. See our rating of the largest employees — is CARDLYTICS INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CARDLYTICS INC technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CARDLYTICS INC stock shows the neutral signal. See more of CARDLYTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on CARDLYTICS INC future price: according to them, CYX price has a max estimate of 16.58 EUR and a min estimate of 15.65 EUR. Read a more detailed CARDLYTICS INC forecast: see what analysts think of CARDLYTICS INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CARDLYTICS INC EBITDA is ‪−31.82 M‬ EUR, and current EBITDA margin is −11.05%. See more stats in CARDLYTICS INC financial statements.